← back to search
Prista Charuworn
Amgen (United States) · US
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Medicine, HBsAg, Discontinuation, Gastroenterology, Internal medicine, and Ibrutinib.
h-index
—
citations
533
works
3
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis
Immunotherapy
2025
cited by
14
position: middle
doi
Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib
Blood Advances
2019
cited by
183
position: middle
doi
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Gastroenterology
2015
cited by
336
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
John M. Pagel
· Eppendorf (Germany)
1
papers (2019–2019)
Peter Hillmen
· Leeds Teaching Hospitals NHS Trust
1
papers (2019–2019)
Margitta Worm
· Charité - Universitätsmedizin Berlin
1
papers (2025–2025)
—
·
1
papers (2025–2025)
Farrukh T. Awan
· Northeast Ohio Medical University
1
papers (2019–2019)
Andrea Wang
· Amgen (United States)
1
papers (2025–2025)
Ahmed Hamdy
· Ain Shams University
1
papers (2019–2019)
—
·
1
papers (2025–2025)
Lawrence F. Eichenfield
· University of San Diego
1
papers (2025–2025)
Anna Schuh
· Science Oxford
1
papers (2019–2019)
—
·
1
papers (2025–2025)
Min Hui Wang
· Ruijin Hospital
1
papers (2019–2019)
Priti Patel
· St. Vincent Hospital
1
papers (2019–2019)
John C. Byrd
· The University of Texas Southwestern Medical Center
1
papers (2019–2019)
Bolan Linghu
· AstraZeneca (United Kingdom)
1
papers (2019–2019)
Richard R. Furman
· Cornell University
1
papers (2019–2019)
Jennifer A. Woyach
· Ohio University
1
papers (2019–2019)
Eric L. Simpson
· Eli Lilly (United States)
1
papers (2025–2025)
Jennifer R. Brown
· Harvard University
1
papers (2019–2019)
Greg Kricorian
· Amgen (United States)
1
papers (2025–2025)